|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Nov 30, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net income (loss) | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Income from Investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expense | ||
| Accounts payable | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Cash withdrawn from trust account | ||
| Cash deposited into trust account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from promissory note – related party | ||
| Repayment from promissory note – related party | ||
| Issuance of Ordinary Shares to Initial Shareholders’ | ||
| Note payable – related party | ||
| Payment of offering Costs | ||
| Issuance of representative shares | ||
| Proceeds from private placement units | ||
| Gross proceeds | ||
| Payment of offering costs, net of reimbursement from underwriter, associated with initial public offering | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash at beginning of year | ||
| Cash at end of year | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Deferred underwriting commissions | ||
| Accretion of carrying value to redemption value | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of founder shares | ||
| Deferred underwriting |
Loading...
